Amy Darukhanavala
Overview
Explore the profile of Amy Darukhanavala including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
64
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Darukhanavala A, Flotte T
Hum Gene Ther
. 2022 Aug;
33(15-16):780-781.
PMID: 35972326
No abstract available.
2.
Williams K, Darukhanavala A, Hicks R, Kelly A
J Clin Transl Endocrinol
. 2022 Jan;
27:100281.
PMID: 34984171
With increasing life expectancy in people with Cystic fibrosis (CF), the focus of clinical care has shifted to management and prevention of non-pulmonary comorbidities. CF related bone disease, defined by...
3.
Darukhanavala A, Merjaneh L, Mason K, Le T
J Clin Transl Endocrinol
. 2021 Dec;
26:100280.
PMID: 34917482
Eating disorders and disturbed body image have been reported in individuals with cystic fibrosis (CF) and may contribute to poor weight gain, reduced lung function and increased mortality. CF individuals...
4.
Wood C, Hasan S, Darukhanavala A, Tangpricha V
J Clin Transl Endocrinol
. 2021 Nov;
26:100273.
PMID: 34815946
Vitamin D deficiency is common in the general population, and even more so in patients with cystic fibrosis. Deficiency is exacerbated in cystic fibrosis patients because of a myriad of...
5.
Mason K, Hasan S, Darukhanavala A, Kutney K
J Clin Transl Endocrinol
. 2021 Nov;
26:100268.
PMID: 34722160
The novel SARS-CoV-2 coronavirus (COVID-19) has become a global health crisis since its initial outbreak in Wuhan, China in December 2019. On January 30, 2020, the WHO recognized the COVID-19...
6.
Darukhanavala A, Puhr S, Dinunno K, Alfego D, Welsh J, Butler L, et al.
Endocrinol Diabetes Metab
. 2021 Jul;
4(3):e00254.
PMID: 34277978
Introduction: Few studies have evaluated glycaemic control using continuous glucose monitoring (CGM) in individuals before and after attendance at a diabetes camp or by comparing control groups at home to...
7.
Darukhanavala A, Kremer T
J Clin Transl Endocrinol
. 2021 Jul;
24:100259.
PMID: 34195009
Background: Cystic fibrosis (CF) affects multiple systems beyond the pulmonary system, including the gastrointestinal and endocrine systems. Many CF clinics focus on pulmonary effects, initiating referrals to other specialties only...
8.
Darukhanavala A, Van Dessel F, Ho J, Hansen M, Kremer T, Alfego D
PLoS One
. 2021 Apr;
16(4):e0250036.
PMID: 33882078
Background: Cystic fibrosis (CF) leads to pancreatic endocrine dysfunction with progressive glycemic disturbance. Approximately 30%-50% of people with CF eventually develop CF-related diabetes (CFRD). Pre-CFRD states progress from indeterminant glycemia...
9.
Choudhry S, McClinton-Powell L, Solomon M, Davis D, Lipton R, Darukhanavala A, et al.
Prog Community Health Partnersh
. 2012 May;
5(4):363-73.
PMID: 22616204
Background: Schools represent a key potential venue for addressing childhood obesity. Objective: To assess the feasibility of Power-Up, an after-school program to decrease obesity risk among African American children, using...
10.
Darukhanavala A, Booth 3rd J, Bromley L, Whitmore H, Imperial J, Penev P
Diabetes Care
. 2011 Aug;
34(10):2259-64.
PMID: 21836106
Objective: Experimental sleep deprivation is accompanied by changes in glucose regulation. However, the effects of chronic sleep insufficiency on insulin secretion and action in populations at high risk for type...